Some individuals report changes in energy, mental clarity, or recovery shortly after treatment, while others experience more gradual improvements as oxidative stress and toxic load are addressed over time
Hazard Mater
No office visits, no scheduling around a provider's availability
Login and ask us What our customers say about the product A satisfied customer says: Fantastic functionality, excellent durability
Given the difficulty of updating all the products on our site in real time or any errors, XFarma.it, all products will be identified through SKU MINSAN (code of the Ministry of Health).
Here we provide an overview of irAEs for current ICIs and their management, aligned with the NCCN Guidelines: Management of ImmunotherapyRelated Toxicities (Version 1.2025), and the Society for Immunotherapy of Cancer (SITC) clinical practice guideline on ICIrelated adverse events (Rapid Update v1.2, published 2024)